CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-19 | Barach Daniele Wolf 10% owner | Other disposition · Warrants | −839,160 | 0 | ||
| 2026-04-13 | Brigido Stephen Pres., Functional Regeneration | Option exercise | +821 | 9,742 | ||
| 2026-04-13 | Brigido Stephen Pres., Functional Regeneration | Shares withheld for taxes | −268 | $1.28 | $343 | 9,474 |
| 2026-04-13 | Brigido Stephen Pres., Functional Regeneration | Option exercise · Restricted Stock Units | −821 | 0 | ||
| 2026-04-13 | Haines John R Senior Exec Vice President | Option exercise | +1,641 | 30,762 | ||
| 2026-04-13 | Haines John R Senior Exec Vice President | Shares withheld for taxes | −583 | $1.28 | $746 | 30,179 |
| 2026-04-13 | Haines John R Senior Exec Vice President | Option exercise · Restricted Stock Units | −1,641 | 0 | ||
| 2026-04-13 | Hariri Robert J Chief Executive Officer | Option exercise | +3,281 | 2,854,735 | ||
| 2026-04-13 | Hariri Robert J Chief Executive Officer | Shares withheld for taxes | −1,182 | $1.28 | $2K | 2,853,553 |
| 2026-04-13 | Hariri Robert J Chief Executive Officer | Option exercise · Restricted Stock Units | −3,281 | 0 | ||
| 2026-01-12 | Parks Diane L. Director | Grant or award | +30,000 | 520,021 | ||
| 2026-01-12 | Diamandis Peter Director | Grant or award | +20,385 | 394,150 | ||
| 2026-01-12 | Ling Geoffrey M.D. Director | Grant or award | +19,231 | 256,026 | ||
| 2026-01-12 | LeVien Vincent Director | Grant or award | +28,847 | 153,847 | ||
| 2026-01-12 | Ling Geoffrey M.D. Director | Grant or award | +19,231 | 256,026 | ||
| 2026-01-12 | LeVien Vincent Director | Grant or award | +28,847 | 153,847 | ||
| 2026-01-12 | Diamandis Peter Director | Grant or award | +20,385 | 394,150 | ||
| 2026-01-12 | Parks Diane L. Director | Grant or award | +30,000 | 520,021 | ||
| 2025-12-29 | LeVien Vincent Director | Grant or award | +125,000 | 125,000 | ||
| 2025-12-29 | LeVien Vincent Director | Grant or award · Stock Options | +156,250 | 156,250 |
Page 2 of 15 · 299 trades